Top 20 genes up-regulated in the nonmetastatic tumor (versus the LN metastases) |
|
|
|
|
0.000024 |
1.56 |
Dual specificity phosphatase 4 |
BC002671.1 |
204015_s_at |
0.000028 |
3.08 |
Transforming growth factor, β-induced, 68 kd |
NM_000358.1 |
201506_at |
0.00003 |
1.99 |
Ras-GTPase-activating protein SH3-domain-binding protein |
BG500067 |
201503_at |
0.000035 |
1.85 |
Non-POU domain containing, octamer-binding |
NM_007363.2 |
200057_s_at |
0.00004 |
1.56 |
Superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult) |
NM_000454.1 |
200642_at |
0.000048 |
2.54 |
KIAA0843 protein |
NM_014945.1 |
205730_s_at |
0.000052 |
80.77 |
Cancer/testis antigen 1 |
AF038567.1 |
211674_x_at |
0.000056 |
1.85 |
Nuclear pore complex interacting protein |
NM_006985.1 |
204538_x_at |
0.000068 |
1.67 |
Integrin, α 6 |
NM_000210.1 |
201656_at |
0.000074 |
3.11 |
Plectin 1, intermediate filament binding protein 500 kd |
Z54367 |
216971_s_at |
0.00008 |
2.15 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 |
NM_016222.1 |
217840_at |
0.000085 |
1.6 |
ATPase, H+ transporting, lysosomal 16 kd, V0 subunit c |
NM_001694.1 |
200954_at |
0.000088 |
1.96 |
Cytoplasmic FMR1 interacting protein 1 |
BC005097.1 |
208923_at |
0.000089 |
1.91 |
Parvulin |
BE674061 |
214224_s_at |
0.000094 |
2.19 |
Sialyltransferase 4C (β-galactoside α-2,3-sialyltransferase) |
NM_006278.1 |
203759_at |
0.000095 |
2.36 |
STIP1 homology and U-Box containing protein 1 |
NM_005861.1 |
217934_x_at |
0.000096 |
2.49 |
Mahogunin, ring finger 1 |
AB011116.1 |
212576_at |
0.000099 |
2.23 |
Nonmetastatic cells 4, protein expressed in |
AL523860 |
212739_s_at |
0.000104 |
1.97 |
MAX interacting protein 1 |
NM_005962.1 |
202364_at |
0.000121 |
2.54 |
Regulator of G-protein signaling 10 |
NM_002925.2 |
204316_at |
Top 20 genes up-regulated in the LN metastases (versus the nonmetastatic tumor) |
|
|
|
|
0 |
6.63 |
Osteopontin |
M83248.1 |
209875_s_at |
0.000007 |
3.4 |
Ornithine decarboxylase 1 |
NM_002539.1 |
200790_at |
0.000007 |
2.2 |
RAB27A, member RAS oncogene family |
BE502030 |
209514_s_at |
0.00001 |
13 |
Baculoviral IAP repeat-containing 7 (livin) |
NM_022161.1 |
220451_s_at |
0.00001 |
6.23 |
Sulfotransferase family, cytosolic, 1C, member 1 |
AF026303.1 |
205342_s_at |
0.00001 |
3.94 |
Preferentially expressed antigen in melanoma |
NM_006115.1 |
204086_at |
0.00001 |
3.67 |
KIAA0930 protein |
AK025608.1 |
217118_s_at |
0.00001 |
2.4 |
Mitochondrial ribosomal protein L35 |
NM_016622.1 |
218890_x_at |
0.000013 |
39.88 |
Chromosome 1 open reading frame 34 |
BC004399.1 |
210652_s_at |
0.000021 |
3.73 |
GREB1 protein |
NM_014668.1 |
205862_at |
0.000023 |
2.45 |
Malate dehydrogenase 1, NAD (soluble) |
NM_005917.1 |
200978_at |
0.000023 |
2.24 |
Adaptor-related protein complex 2, σ 1 subunit |
NM_021575.1 |
208074_s_at |
0.000024 |
2.42 |
N-Acylsphingosine amidohydrolase (acid ceramidase) 1 |
U47674.1 |
210980_s_at |
0.000025 |
2.07 |
Adaptor-related protein complex 2, σ 1 subunit |
BC006337.1 |
211047_x_at |
0.000027 |
1.9 |
Sorting nexin 10 |
NM_013322.1 |
218404_at |
0.000028 |
11.05 |
Aldehyde dehydrogenase 1 family, member A1 |
NM_000689.1 |
212224_at |
0.00003 |
6.06 |
Serine (or cysteine) proteinase inhibitor, clade F, member 1 |
NM_002615.1 |
202283_at |
0.00003 |
2.92 |
Neutral sphingomyelinase (N-SMase) activation associated factor |
NM_003580.1 |
203269_at |
0.000032 |
4519.89 |
G antigen 4 |
NM_001473.1 |
207663_x_at |
0.000032 |
2.36 |
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
AI934569 |
213702_x_at |